- Home
- / EuBiologics
EuBiologics
Stock Price
₩15.5 K
2024-10-29
Market Capitalization
₩541.1 B
2024-10-29
Revenue
₩149.2 B
FY, 2025
EuBiologics Summary
Company Summary
- Overview
- EuBiologics is a contract research and manufacturing organization. It is engaged in vaccine development and the development of advanced biopharmaceuticals, manufacturing technologies and support services.
- Type
- Public
- Status
- Active
- Founded
- 2010
- Website
- http://www.eubiologics.com/
- Cybersecurity rating
- ESG rating
Table of Contents
EuBiologics Financials
Summary Financials
- Revenue (FY, 2025)
- ₩149.2B
- Gross profit (FY, 2025)
- ₩95.4B
- Net income (FY, 2025)
- ₩41.3B
- Cash (FY, 2025)
- ₩23.7B
- EBIT (FY, 2025)
- ₩56.1B
- Enterprise value
- $521.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026